60
Pharma & HealthcareHold
Mirae Asset Healthcare
Mirae Asset · Direct–Growth · rank #5 of 19 by Smart Score
Data updated
Trailing returns
1 Year
19.6%
+21.7% vs index
3 Years
23.0%
+13.2% vs index
5 Years
15.9%
+6.4% vs index
Since launch
22.3%
Year-by-year performance
2021
+28.6%-2.1% vs index
2022
-10.5%-14.3% vs index
2023
+36.1%+9.5% vs index
2024
+41.2%+25.6% vs index
2025
-2.0%-9.7% vs index
2026
+22.8%+26.4% vs index
Why this score
Mirae Asset Healthcare scores 60/100 — #5 of 19 Pharma & Healthcare fund (Hold). It stands out for 3y return and expense ratio — beating 77% of peers on 3y return. The main drag is its volatility (better than only 16% of peers).
Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.
3Y return22.98% · 77th percentile in category
Expense ratio0.61% · 97th percentile in category
Volatility16.17 · 16th percentile in category
Alpha3.06 · 22nd percentile in category
5Y return15.91% · 61st percentile in category
Fund size3555.18 Cr · 76th percentile in category
Top holdings
1.Sun Pharmaceutical Industries Ltd10.9%
2.Divi's Laboratories Ltd9.91%
3.Torrent Pharmaceuticals Ltd7.06%
4.Apollo Hospitals Enterprise Ltd5.91%
5.Laurus Labs Ltd5.24%
29 disclosed equity positions · portfolio as of Aug 2026 · weights are % of total corpus.